share_log

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%

空頭股數在Q生物醫藥公司(OTCMKTS:QBIO)下跌99.5%
kopsource ·  2022/07/29 16:11

Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% from the June 30th total of 19,200 shares. Based on an average daily trading volume, of 844,800 shares, the short-interest ratio is currently 0.0 days.

Q BioMed Inc.(場外交易代碼:QBIO-GET Rating)是7月份空頭股數價格大幅下降的接收方。截至7月15日,空頭股數共有100股,與6月30日的19,200股相比,下降了99.5%。以日均成交量844,800股計算,目前短息比為0.0天。

Q BioMed Price Performance

Q BioMed性價比

Shares of QBIO traded down $0.01 during mid-day trading on Friday, hitting $0.17. 453,350 shares of the company's stock were exchanged, compared to its average volume of 234,883. The company has a market cap of $7.05 million, a PE ratio of -0.55 and a beta of 1.74. Q BioMed has a 52 week low of $0.04 and a 52 week high of $0.90. The company has a 50-day simple moving average of $0.08 and a 200 day simple moving average of $0.22.

QBIO的股價在週五午盤交易中下跌0.01美元,觸及0.17美元。該公司股票成交量為453,350股,而其平均成交量為234,883股。該公司市值為705萬美元,市盈率為-0.55,貝塔係數為1.74。Q BioMed的52周低點為0.04美元,52周高點為0.90美元。該公司的50日簡單移動均線切入位在0.08美元,200日簡單移動均線切入位在0.22美元。

Get
到達
Q BioMed
Q BioMed
alerts:
警報:

About Q BioMed

關於Q BioMed

(Get Rating)

(獲取評級)

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc.是一家生物醫學加速和開發公司,專注於許可、收購和向生命科學和醫療保健公司提供資源。該公司提供氯化鍶SR89和美沙酮,這是一種治療轉移性骨癌疼痛的放射性藥物。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
  • The One Question You Have to Ask Before Investing in INTC Stock
  • Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
  • Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
  • Why Apple Shares May Have Room to Move Higher After Earnings
  • Windfall Profits Have Exxon Mobil On Track For New Highs
  • 免費獲取有關Q BioMed(QBIO)的StockNews.com研究報告
  • 在投資INTC股票之前,你必須問一個問題
  • 家得寶:引領熊市的美麗而乏味的股票
  • CRISPR治療公司可能是隱藏在平坦視線中的登月計劃嗎?
  • 為什麼蘋果股價在盈利後有走高的空間
  • 暴利使埃克森美孚有望創下新高

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.

接受Q BioMed Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Q BioMed和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論